ArticleFrontiers in oncology2022
COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation.
Xiangyi Zan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Xiangyi Zan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.